Most Cited & Viewed

Citations Article
 
Developments and Challenges for mAb-Based Therapeutics
 
Antibody Glycosylation and Inflammation
 
Antibody Conjugates: From Heterogeneous Populations to Defined Reagents
 
Targeting sTNF/TNFR1 Signaling as a New Therapeutic Strategy
 
In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments
 
Antibody Structure and Function: The Basis for Engineering Therapeutics
 
Antibody Drug Conjugates as Cancer Therapeutics
 
Design and Production of Bispecific Antibodies
 
David vs. Goliath: The Structure, Function, and Clinical Prospects of Antibody Fragments
 
Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer
Views Article
Antibody Glycosylation and Inflammation
Antibody Drug Conjugates as Cancer Therapeutics
In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments
Developments and Challenges for mAb-Based Therapeutics
Communication between B-Cells and Microbiota for the Maintenance of Intestinal Homeostasis
Antibody Structure and Function: The Basis for Engineering Therapeutics
Shark Variable New Antigen Receptor (VNAR) Single Domain Antibody Fragments: Stability and Diagnostic Applications
Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer
IgG Antibody 3D Structures and Dynamics
Antibody Fragments and Their Purification by Protein L Affinity Chromatography
Back to TopTop